Dosage Forms & Drug Delivery Systems – Page 28

Suppository Deformation after excipient change: CAPA with effectiveness checks for auditors

The identification of symptoms signalling potential issues is critical in the early stages of the investigation. Apparent signs of suppository deformation can manifest through various observations:Click to read the full…

Cooling Tunnel Variability after temperature excursion: process controls for moulding, filling, and storage

The presence of cooling tunnel variability can manifest through various symptoms that must be diligently monitored during production. Some primary indicators include:Click to read the full article.

Pet Failure during PAI readiness: FDA-ready investigation report and batch disposition

Recognizing symptoms and signals of a pet failure is critical in addressing production or quality lapses efficiently. Symptoms may present variably within the manufacturing environment, often manifesting as deviations from…

Ph Drift during cooling and moulding: process controls for moulding, filling, and storage

Identifying the symptoms of pH drift during cooling and moulding is crucial for prompt action. The most common signals observed include:Click to read the full article.

Melting Point Failure in suppository manufacturing: process controls for moulding, filling, and storage

Melting point failures manifest in various ways during the manufacturing process of suppositories. Some of the symptoms or signals indicating a potential issue include:Click to read the full article.

Phase Separation in vaginal gel production: process controls for moulding, filling, and storage

Phase separation in vaginal gel production can manifest through various physical indicators. These symptoms may serve as early warning signals that warrant immediate attention:Click to read the full article.

Em Excursion during PAI readiness: packaging integrity and CCIT justification

Identification of symptoms or signals that indicate an em excursion is critical in any investigation. These could manifest in various forms, including but not limited to:Click to read the full…

Viscosity Drift after excipient change: process controls for moulding, filling, and storage

Recognizing the signs of viscosity drift is crucial for effective monitoring and response. Symptoms may present as quality control deviations, customer complaints, process inefficiencies, or anomalies detected during routine testing.…

Pet Failure after excipient change: process controls for moulding, filling, and storage

Addressing Process Control Challenges Following Excipient Changes to Prevent Pet Failure In the pharmaceutical manufacturing environment, a significant change to excipients can lead to unexpected challenges, including the risk of…

Pet Failure at stability pull: risk assessment for sterility assurance

Identifying symptoms early is essential for determining the magnitude and potential impact of a pet failure at the stability pull stage. The following signals may indicate underlying issues:Click to read…

Packaging Leakage Complaint during cooling and moulding: process controls for moulding, filling, and storage

Identifying symptoms or signals is the first step in addressing packaging leakage during the cooling and moulding stages. Common signs that may indicate a leakage problem include:Click to read the…

Fill Weight Variability in vaginal gel production: manufacturing vs lab root cause decision tree

Fill weight variability can manifest in numerous ways throughout the production and quality control processes. Some of the primary symptoms to monitor include:Click to read the full article.